Dr Lal PathLabs has released its second quarter results. The company's profit has increased by 18 percent compared to last year. At the same time, there has been an increase of about 10 percent in income. EBITDA has also increased by about 14 percent on a year-on-year basis. Margins have also been better than last year. At the same time, the company's profit, EBITDA and margins have been better than market estimates. However, the income was slightly less than the estimate.

Dividend announcement

Along with the results, the company has announced the second interim dividend for its investors. The company will give an interim dividend of Rs 6 per share to its investors. The company has fixed the record date of 5 November 2024 for the dividend. The company has issued these announcements after the market closed. In Wednesday's trading, the stock closed at 3252 with a gain of about 2 percent. How were the quarterly results The company's profit has increased by 18.2 percent to Rs 130.8 crore compared to last year. At the same time, the company's income has increased by 9.8 percent to Rs 660.2 crore. The company's EBITDA has increased by 13.9 percent to Rs 202 crore. At the same time, the margins have been at 30.7 percent, which was at the level of 29.6 percent a year ago. How were the results compared to market estimates The company's profit, EBITDA and margins have been better than the estimates received from CNBC TV 18 poll. On the other hand, the income has been slightly less than the estimates. The company's profit has been 4.9 percent more than the market's estimate. On the other hand, EBITDA has been 3.5 percent above the estimates. In the poll, the margin was estimated to be 29.2 percent, however the margin was 30.7 percent. On the other hand, the income has been 1.5 percent less than the market's estimate.